GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare and Mass General Brigham Collaborate on an AI Algorithm to Predict Missed Care Opportunities

GE HealthCare and Mass General Brigham announced, as part of its initial collaboration, the co-development of an artificial intelligence (AI) algorithm that will help increase operations effectiveness and productivity. The first innovative AI application from the collaboration is the schedule predictions dashboard of Radiology Operations Module (ROM), a digital imaging tool that helps optimize scheduling, reduce cost, and free providers from administrative burden, allowing more time for the clinician-patient relationship. ROM is commercially available to healthcare institutions.

The actionable insights driven by AI and machine learning are designed to help improve both departmental and enterprise-wide productivity and administrative efficiency. By 2025, the U.S. is estimated to have a shortage of approximately 446,000 home health aides, 95,000 nursing assistants, 98,700 medical, and lab technologists and technicians, and more than 29,000 nurse practitioners, according to a report conducted by industry market analytic firm . Health systems will need to rely on technology to help solve some of these challenges.

"Amid the vast sea of data and the heavy tasks that divert healthcare providers from patient care, our collaboration with Mass General Brigham is groundbreaking. Through the fusion of distinctive datasets and cutting-edge machine learning methods, harnessing the synergy of clinical and technical proficiency, we are ushering in unprecedented healthcare advancements,” said Parminder Bhatia, Chief AI Officer of GE HealthCare.

Operational AI-enabled tools can address challenges that often pose a threat to patient care such as cost of care, and hospital inefficiencies. When a patient misses an appointment, fails to schedule a follow up or is late, also known as missed care opportunities (MCO), the impact can be significant. The co-developed algorithm is intended to predict MCO and late arrivals, which could help increase flexibility and streamline administrative operations, improve patient satisfaction, and better accommodate urgent, inpatients, or walk in appointments. In preliminary tests, the algorithm was able to predict the missed care opportunity correctly, at rates of up to 96%, with limited false positives1.

“Utilizing operational AI and machine learning can bring providers together and streamline data sets,” said Keith Dreyer, DO, PhD, Chief Data Science Officer, Mass General Brigham. “The strategic use of AI offers great potential for the future of healthcare and we’re proud to be at the forefront of the movement. This technology has the potential to reduce burnout and allow physicians to spend more time with patients, which may ultimately lead to better outcomes.”

The 10-year commitment to drive innovation between GE HealthCare and Mass General Brigham was first signed in 2017 to explore the use of AI across a broad range of diagnostic and treatment paradigms. GE HealthCare and Mass General Brigham are working to implement AI in ways that will support each patient’s journey.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Follow us on , , , , and for the latest news, or visit our for more information.

1 Results are based on testing at one Mass General Brigham location. In testing, the range of prediction of missed care was 67% to 96%. Results may not be typical.

* Mass General Brigham was not compensated for this testimonial, but has a financial stake in the commercial success of ROM. The statements by Mass General Brigham described here are based on results that were achieved in its unique setting. Since there is no “typical” hospital and many variables exist, i.e., hospital size, case mix, etc. There can be no guarantee that other customers will achieve the same results.

EN
06/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

Moody's Ratings assigns Baa2 rating to GE Healthcare's sr. notes; stab...

Moody's Ratings (Moody's) assigned a Baa2 rating to GE HealthCare Technologies Inc.'s ("GE HealthCare") proposed offering of senior unsecured notes. There are no changes to GE HealthCare's existing ratings including the Baa2 issuer rating, Baa2 senior unsecured notes ratings and (P)Baa2 senior unsec...

 PRESS RELEASE

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premiu...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense breast tissue, making them four to six times more likely to receive a breast cancer diagnosis.4 Early d...

 PRESS RELEASE

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetr...

 PRESS RELEASE

GE HealthCare expands invasive cardiology solutions portfolio with Alt...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Cardiovascular disease (CVD) has nearly doubled over the past three decades, affecting more than 500 ...

 PRESS RELEASE

GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Por...

LAS VEGAS--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released – edge, storage, vendor neutral archive and data migration.i These cloud solutions, are designed to help enhance healthcare organizations’ efficiency and precision, streamline workflows, and optimize the use of capital and IT resources. The growing volume and complexity of patient cases are putting increasing pressure on hospitals’ IT systems, driving the ne...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch